Hemostatic Needles: Controlling Hemostasis Time by a Catecholamine Oxidative Pathway

Most infectious human viruses are generally found in the bloodstream after being released by infected organs. Thus, hemorrhage in patients, whose blood contains infectious viruses might be a significant risk for secondary infections. In this work, a self-sealing hemostatic needle that causes no bleeding even after its removal is reported. The materials used for the self-sealing needles are inspired by mussel adhesive polysaccharide, chitosan-catechol, which shows a rapid phase transition from a solid phase (i.e., a thin film) to an adhesive gel upon coming into contact with blood. We found that the self-sealing time for the complete hemostasis depends on the oxidation pathway of the conjugated catechol. For high-temperature oxidation (i.e., 60 degrees C), Michael addition is a dominant oxidative coupling reaction, which weakens the chitosan-catechol attachment force on the needle surface. Thus, the film is easily transferred to the hemorrhaging sites, with the result that there is no bleeding even after a short injection time (<5 s). In contrast, during low-temperature oxidation (4 degrees C), Schiff base formation is dominant, which strengthens the film attachment force on the needle surface, resulting in continued bleeding owing to a dearth of tissue transfer after the injection.

Automated summary

This study introduced a self-sealing hemostatic needle inspired by mussel adhesive polysaccharide, chitosan-catechol, with the self-sealing time for complete hemostasis depending on the oxidation pathway of the conjugated catechol. High-temperature oxidation weakens the attachment force on the needle surface, facilitating transfer to hemorrhaging sites, while low-temperature oxidation strengthens the attachment force, leading to continued bleeding.